Abstract
Inflammation and glucocorticoid therapy are major factors in the growth retardation seen in children with severe forms of juvenile idiopathic arthritis (JIA).
Highlights
Inflammation and glucocorticoid therapy are major factors in the growth retardation seen in children with severe forms of juvenile idiopathic arthritis (JIA)
The objective of the this study was to evaluate effects of antirheumatic treatment with recombinant humanised monoclonal antibody that acts as IL-6R antagonist on longitudinal growth
Nineteen patients with systemic JIA was included into the study (8 boys and 11 girls)
Summary
Inflammation and glucocorticoid therapy are major factors in the growth retardation seen in children with severe forms of juvenile idiopathic arthritis (JIA). Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis From 21st European Pediatric Rheumatology (PReS) Congress Belgrade, Serbia. Introduction Inflammation and glucocorticoid therapy are major factors in the growth retardation seen in children with severe forms of juvenile idiopathic arthritis (JIA).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
